• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信使核糖核酸疫苗的可电离脂质纳米颗粒通过Toll样受体4引发核因子κB和干扰素调节因子反应。

Ionizable lipid nanoparticles of mRNA vaccines elicit NF-κB and IRF responses through toll-like receptor 4.

作者信息

Zelkoski Amanda E, Lu Zhongyan, Sukumar Gauthaman, Dalgard Clifton, Said Hooda, Alameh Mohamad-Gabriel, Mitre Edward, Malloy Allison M W

机构信息

Department of Pediatrics, Uniformed Services University of Health Sciences, Bethesda, MD, USA.

Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.

出版信息

NPJ Vaccines. 2025 Apr 17;10(1):73. doi: 10.1038/s41541-025-01124-x.

DOI:10.1038/s41541-025-01124-x
PMID:40246950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12006303/
Abstract

Ionizable lipid nanoparticles (LNP) that have enabled the success of messenger RNA (mRNA) vaccines have been shown to be immunostimulatory in the absence of mRNA. However, the mechanisms through which they activate innate immune cells is incompletely understood. Using a monocyte cell line, we compared the ability of three LNP formulations to activate transcription factors Nuclear Factor-kappa B (NF-κB) and Interferon Regulatory Factor (IRF). Comparison of signaling in knockout cell lines illustrated a role for Toll-like receptor (TLR) 4 in initiation of this signaling cascade and the contribution of the ionizable lipid component. Activation induced by empty LNPs was similar to that induced by LNPs containing mRNA, indicating that LNPs may provide the majority of innate stimulation for the mRNA vaccine platform. Our findings demonstrate that ionizable lipids within LNPs signal through TLR4 to activate NF-κB and IRF, identifying a mechanism for innate activation that can be optimized for adjuvant design.

摘要

已证明,能够使信使核糖核酸(mRNA)疫苗取得成功的可电离脂质纳米颗粒(LNP)在没有mRNA的情况下具有免疫刺激作用。然而,它们激活先天免疫细胞的机制尚未完全明确。我们使用一种单核细胞系,比较了三种LNP制剂激活转录因子核因子κB(NF-κB)和干扰素调节因子(IRF)的能力。在基因敲除细胞系中的信号传导比较表明,Toll样受体(TLR)4在该信号级联反应的启动中发挥作用,以及可电离脂质成分的贡献。空LNP诱导的激活与含mRNA的LNP诱导的激活相似,这表明LNP可能为mRNA疫苗平台提供了大部分先天刺激。我们的研究结果表明,LNP中的可电离脂质通过TLR4发出信号以激活NF-κB和IRF,确定了一种可针对佐剂设计进行优化的先天激活机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/5b9ae14a1345/41541_2025_1124_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/8fb8fb80e1e6/41541_2025_1124_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/0360d1f69ca8/41541_2025_1124_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/80b391748277/41541_2025_1124_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/ab8be716198b/41541_2025_1124_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/5b9ae14a1345/41541_2025_1124_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/8fb8fb80e1e6/41541_2025_1124_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/0360d1f69ca8/41541_2025_1124_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/80b391748277/41541_2025_1124_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/ab8be716198b/41541_2025_1124_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/12006303/5b9ae14a1345/41541_2025_1124_Fig5_HTML.jpg

相似文献

1
Ionizable lipid nanoparticles of mRNA vaccines elicit NF-κB and IRF responses through toll-like receptor 4.信使核糖核酸疫苗的可电离脂质纳米颗粒通过Toll样受体4引发核因子κB和干扰素调节因子反应。
NPJ Vaccines. 2025 Apr 17;10(1):73. doi: 10.1038/s41541-025-01124-x.
2
Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway.脂质纳米颗粒作为诺如病毒VLP疫苗的佐剂,通过TLR9和I型干扰素依赖性途径增强细胞免疫和体液免疫反应。
J Virol. 2024 Dec 17;98(12):e0169924. doi: 10.1128/jvi.01699-24. Epub 2024 Nov 4.
3
Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis.脂质纳米颗粒通过 Toll 样受体 4 和髓样分化蛋白 88 轴在小鼠中引起反应原性和疾病行为。
ACS Nano. 2024 Sep 10;18(36):24842-24859. doi: 10.1021/acsnano.4c05088. Epub 2024 Aug 26.
4
TLR7-Adjuvanted Ionizable Lipid Nanoparticles for mRNA Vaccine Delivery.用于mRNA疫苗递送的TLR7佐剂可电离脂质纳米颗粒
AAPS J. 2025 Apr 25;27(4):80. doi: 10.1208/s12248-025-01073-2.
5
Amplification of Protein Expression by Self-Amplifying mRNA Delivered in Lipid Nanoparticles Containing a β-Aminoester Ionizable Lipid Correlates with Reduced Innate Immune Activation.脂质纳米颗粒递送的自扩增 mRNA 通过 β-氨基酯可离子化脂质扩增蛋白表达与降低固有免疫激活相关。
ACS Nano. 2024 Oct 15;18(41):28311-28324. doi: 10.1021/acsnano.4c09677. Epub 2024 Oct 1.
6
Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.基于脂质纳米颗粒的信使核糖核酸候选物引发强烈的T细胞反应。
Biomater Sci. 2023 Jan 31;11(3):964-974. doi: 10.1039/d2bm01581a.
7
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice.用于佐剂配方的脂质纳米颗粒组合物调节四价流感疫苗接种小鼠流感病毒感染后的疾病。
Front Immunol. 2024 Apr 22;15:1370564. doi: 10.3389/fimmu.2024.1370564. eCollection 2024.
8
An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses.一种带生育酚支架的可离子化脂质材料,作为一种 mRNA 疫苗平台,可有效诱导细胞毒性 T 细胞反应。
ACS Nano. 2023 Oct 10;17(19):18758-18774. doi: 10.1021/acsnano.3c02251. Epub 2023 Sep 26.
9
Chemistry of Lipid Nanoparticles for RNA Delivery.脂质纳米颗粒的 RNA 递送化学。
Acc Chem Res. 2022 Jan 4;55(1):2-12. doi: 10.1021/acs.accounts.1c00544. Epub 2021 Dec 1.
10
Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions.低炎症性基于脂质纳米颗粒的mRNA疫苗可诱导针对H5N1流感病毒的保护性免疫,且不良反应减少。
Mol Ther. 2025 Feb 5;33(2):529-547. doi: 10.1016/j.ymthe.2024.12.032. Epub 2024 Dec 17.

引用本文的文献

1
Decrypting the Immune Symphony for RNA Vaccines.解读RNA疫苗的免疫乐章
Vaccines (Basel). 2025 Aug 20;13(8):882. doi: 10.3390/vaccines13080882.
2
Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological Efficacy.重组严重急性呼吸综合征冠状病毒2疫苗中壳聚糖、脂质纳米颗粒和明矾佐剂的比较分析:对其免疫原性和血清学效力的评估
Vaccines (Basel). 2025 Jul 24;13(8):788. doi: 10.3390/vaccines13080788.
3
Innate Immune Response to Powassan Virus Infection: Progress Toward Infection Control.

本文引用的文献

1
Targeting Metastasis in Head and Neck Squamous Cell Carcinoma Using Follistatin mRNA Lipid Nanoparticles.使用卵泡抑素信使核糖核酸脂质纳米颗粒靶向治疗头颈部鳞状细胞癌转移
ACS Nano. 2024 Dec 10;18(49):33330-33347. doi: 10.1021/acsnano.4c06930. Epub 2024 Nov 21.
2
Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d.带正电荷的脂质头基通过与 TLR4 和 CD1d 受体结合,驱动免疫反应对脂质纳米颗粒。
Nat Biomed Eng. 2024 Nov;8(11):1483-1498. doi: 10.1038/s41551-024-01256-w. Epub 2024 Oct 3.
3
Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis.
对波瓦桑病毒感染的先天免疫反应:感染控制方面的进展
Vaccines (Basel). 2025 Jul 15;13(7):754. doi: 10.3390/vaccines13070754.
4
Efficacy and safety of a novel multivalent mRNA vaccine against SARS-CoV-2 in experimental animals.一种新型多价抗SARS-CoV-2 mRNA疫苗在实验动物中的有效性和安全性。
Sci Rep. 2025 Jul 1;15(1):21831. doi: 10.1038/s41598-025-07661-8.
脂质纳米颗粒通过 Toll 样受体 4 和髓样分化蛋白 88 轴在小鼠中引起反应原性和疾病行为。
ACS Nano. 2024 Sep 10;18(36):24842-24859. doi: 10.1021/acsnano.4c05088. Epub 2024 Aug 26.
4
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability.两种全球上市的新冠疫苗的mRNA-LNP成分对效力和稳定性的影响。
NPJ Vaccines. 2023 Oct 11;8(1):156. doi: 10.1038/s41541-023-00751-6.
5
Saponin-based adjuvants enhance antigen cross-presentation in human CD11c CD1c CD5 CD163 conventional type 2 dendritic cells.基于皂素的佐剂增强了人类 CD11c+CD1c+CD5+CD163+常规 2 型树突状细胞的抗原交叉呈递。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2023-007082.
6
Waning cellular immune responses and predictive factors in maintaining cellular immunity against SARS-CoV-2 six months after BNT162b2 mRNA vaccination.BNT162b2 mRNA 疫苗接种 6 个月后细胞免疫对 SARS-CoV-2 的衰减和预测因素。
Sci Rep. 2023 Jun 13;13(1):9607. doi: 10.1038/s41598-023-36397-6.
7
mRNA Vaccine Platform: mRNA Production and Delivery.信使核糖核酸疫苗平台:信使核糖核酸的生产与递送
Russ J Bioorg Chem. 2023;49(2):220-235. doi: 10.1134/S1068162023020152. Epub 2023 May 19.
8
CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein.CpG 1018是流感核蛋白的有效佐剂。
Vaccines (Basel). 2023 Mar 14;11(3):649. doi: 10.3390/vaccines11030649.
9
Durability of immune responses to mRNA booster vaccination against COVID-19.mRNA 疫苗加强针接种后对 COVID-19 免疫反应的持久性。
J Clin Invest. 2023 May 15;133(10):e167955. doi: 10.1172/JCI167955.
10
NF-κB in monocytes and macrophages - an inflammatory master regulator in multitalented immune cells.单核细胞和巨噬细胞中的 NF-κB——多功能免疫细胞中的炎症主调控因子。
Front Immunol. 2023 Feb 23;14:1134661. doi: 10.3389/fimmu.2023.1134661. eCollection 2023.